Patient education responsibility, specialty and administration information from the internal medicine viewpoint
Ludwig, W.D.
Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 91(7): 657-661
1997
ISSN/ISBN: 1431-7621 PMID: 9527464 Document Number: 477678
Drug therapy requires both the thorough education of the patient by the physician and the patient's consent. The contents of the patient education should be based on the urgency of drug therapy, the patient's educational background, and his level of knowledge. Besides the instructions and explanations given to medicine users by physicians or pharmacists, the written patient information leaflet represents the main source of information. The objectives of the written information concerning a pharmaceutical product are to provide patients with clear information about the drug and, thus, to improve the drug compliance. Guidelines of the European Community (EC) for the writing of drug information leaflets (guideline 92/27) will hopefully lead to a more consumer-oriented drug information. The data sheet should give medical specialists the detailed information needed to safely use the drug. The note for guidance "Summary of Product Characteristics", recently proposed by the CPMP (Committee for Proprietary Medicinal Products) of the EC, provides detailed instructions on how to present drug information.